BPC-157 + TB-500 Blend. 30mg / 30mg
Original price was: € 209,00.€ 179,00Current price is: € 179,00.
To make room for a newly tested batch, products from the previous batch are temporarily reduced.
Same verified quality — price returns to normal once sold out.
BPC-157 + TB-500 30 mg / 30 mg – Grail Formula Quality.
Researched and verified with Liquilabs s.r.o. Czechia.
Analytical testing confirms high purity for both peptides, assay content verified at BPC-157 31.6 mg and TB-500 33.8 mg, with endotoxin levels below 0.001 EU/mg.
No detectable levels of heavy metals including arsenic, cadmium, cobalt, lead, nickel, mercury and vanadium.
Supplied as a 60 mg lyophilized peptide blend with full COA traceability.
For research use only — not for human or veterinary use.
Availability: In stock: ships within 1 day after payment confirmation.
For research use only — not for human or veterinary use.
Analytical Verification (COA)
Each batch of BPC-157 + TB-500 supplied by Grail Formula undergoes independent third-party laboratory verification to confirm compound identity, assay content, purity and microbiological safety.
Analytical testing for this batch was performed by Liquilabs s.r.o. (Czechia) using validated chromatographic and spectrometric techniques.
Batch: GF-BPCTB30-B241
Key analytical results include:
- BPC-157 Assay Content: 31.6 mg
- TB-500 Assay Content: 33.8 mg
- BPC-157 Identification – Retention Time: 0.992
- TB-500 Identification – Retention Time: 0.993
- BPC-157 Identification – Spectrum: 997
- TB-500 Identification – Spectrum: 995
- Purity: high purity confirmed for both peptides
- Bacterial Endotoxins: below 0.001 EU per mg
- Total Aerobic Microbial Count: not detected
- Total Yeast and Mold Count: not detected
Independent heavy metal screening confirmed no detectable levels of arsenic, cadmium, cobalt, lead, nickel, mercury or vanadium.
These analytical procedures ensure traceability, purity verification and laboratory-grade compound consistency.
Product Overview
BPC-157 + TB-500 is a dual peptide research blend studied in controlled laboratory environments focused on peptide-mediated signalling pathways and molecular regulatory systems.
The combination is commonly investigated in biochemical research for its interaction with peptide signalling mechanisms and molecular processes.
This preparation contains a total of 60 mg of high purity lyophilized peptides supplied in a sealed research vial. The lyophilization process preserves peptide stability and allows researchers to reconstitute the compounds for controlled in vitro experimentation.
Due to the defined dual-peptide structure and stable analytical profile, this blend is frequently referenced in experimental peptide research models.
Compound Overview
BPC-157 and Thymosin Beta 4 (TB-500) are synthetic peptides studied in biochemical research for their interaction with signalling pathways and regulatory systems.
Within experimental models, these compounds are commonly investigated for their interaction with peptide-mediated signalling networks and molecular mechanisms.
Because of their combined molecular profile, this blend is frequently used in laboratory studies examining peptide signalling and regulatory processes.
Historical Background and Scientific Context
Scientific interest in synthetic peptides has expanded significantly with advances in molecular biology and biochemical research.
Peptides such as BPC-157 and TB-500 have been developed to explore signalling pathways and receptor interactions in controlled laboratory environments.
This has enabled deeper investigation into molecular mechanisms and peptide-mediated biological processes.
Mechanistic Focus in Research
Within experimental laboratory settings, this peptide blend is commonly studied in relation to peptide-mediated signalling pathways.
Research investigations commonly explore the compounds in experimental models examining:
- Peptide signalling pathways
- Regulatory network interactions
- Peptide interaction dynamics
- Intracellular signalling mechanisms
- Comparative peptide research
- Molecular signalling pathway analysis
- Receptor interaction modelling
These experimental models allow scientists to investigate molecular mechanisms involved in peptide-mediated signalling processes.
Research Applications
In controlled research environments, this peptide blend may be utilised in experimental models designed to explore peptide signalling systems and molecular interactions.
Examples of research applications include:
- Peptide signalling pathway investigation
- Receptor interaction research
- Intracellular signalling modelling
- Comparative peptide studies
- Molecular pathway analysis
- Controlled in vitro research
- Laboratory signalling studies
Grail Formula Quality
Every Grail Formula research compound is produced under strict quality control procedures designed to support reliable laboratory experimentation.
Each batch undergoes independent analytical testing to verify:
- Compound identity
- Assay accuracy
- Purity confirmation
- Microbial safety
- Endotoxin levels
- Heavy metal screening
- Full batch traceability
All testing is performed by independent laboratories to ensure transparent verification and reproducible research material.
Research Use Limitation
- Used solely for in vitro experiments
- Not permitted for clinical trials involving humans
- Not permitted for human or veterinary administration
- Not permitted for investigational human use
- Independently analysed by Liquilabs s.r.o. Czechia
- Dual peptide blend with verified analytical composition
- Assay content: BPC-157 31.6 mg and TB-500 33.8 mg
- Endotoxin level below 0.001 EU/mg
- No detectable heavy metals or microbial contamination
- High-purity peptide combination for controlled laboratory research
- For research use only – not for human or veterinary use
For laboratory research only. Not intended for human consumption, injection, or cosmetic use.
This product is for research purposes only. Not for human use or diagnostic/therapeutic applications. Keep out of reach of children.
